Independent reference · Facts sourced from CPSC, ENERGY STAR and DOE Record verified Aug 18, 2026
Active recall — stop using this product now.
Remedy: free repair · About 50,330 units
Recall No. 26-157 Published December 18, 2025

Mamisan Pain Relieving Topical Ointment

The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children. Manufactured by MiramarLab and sold at Walmart and Target stores nationwide and online at Target.com from April 2024 – October 2025 for about $10.

Recalled Mamisan Licodaine Ointment jar UPC - 860006498115
What you are looking at

Recalled Mamisan Licodaine Ointment jar UPC - 860006498115

Image: CPSC recall notice Two more views

Check the label first

Compare every letter, number, space and suffix. A similar-looking product with a different suffix may not be part of this recall.

Affected model numbers
UPC codes
860006498115

Why it was recalled

The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.

0
Incident reports to the firm
0
Injuries reported
0
SaferProducts.gov reports

None reported

The official remedy

Remedy type: repair
01
What to do

Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.

Product and sales details

ManufacturerMiramarLab, of Doral, Florida
UnitsAbout 50,330
Made inUnited States
Sold atWalmart and Target stores nationwide and online at Target.com
Sales periodApril 2024 – October 2025
PriceAbout $10

How to reach the firm

Phone
855-752-6869
9 a.m. to 4 p.m. PT Monday through Friday
Email

Verify phone numbers, hours and web addresses on the current CPSC notice before contacting the firm.